[Amiodarone-induced torsade de pointes--five case reports]
- PMID: 15226788
[Amiodarone-induced torsade de pointes--five case reports]
Abstract
Five patients with amiodarone-induced QT prolongation and torsade de pointes are described. Hypokalemia was present in three patients, marked bradycardia - in two, and T-wave alternans - also in two patients. Patients with negative T waves in precordial leads were at higher risk of ventricular fibrillation than the patients with positive T waves. Beta-blocker, lidocaine and, in two patients, tosylate bretylate were effective. All patients survived to hospital discharge, however, one patient died four months later.
Similar articles
-
Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.Can J Cardiol. 1997 Apr;13(4):383-6. Can J Cardiol. 1997. PMID: 9141970 Review.
-
[Torsades de pointes ventricular tachycardia induced by intravenous amiodarone].Orv Hetil. 2003 Feb 2;144(5):241-7. Orv Hetil. 2003. PMID: 12647553 Review. Hungarian.
-
Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndrome.Europace. 2008 Jan;10(1):112-3. doi: 10.1093/europace/eum252. Epub 2007 Nov 15. Europace. 2008. PMID: 18006559 No abstract available.
-
Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.Circulation. 1992 Nov;86(5):1376-82. doi: 10.1161/01.cir.86.5.1376. Circulation. 1992. PMID: 1423949
-
[Torsade de pointes during anti-arrhythmia treatment with amiodarone].Schweiz Rundsch Med Prax. 1993 Feb 9;82(6):173-5. Schweiz Rundsch Med Prax. 1993. PMID: 7679520 German.
Cited by
-
Withdrawal of prenylamine: perspectives on pharmacological, clinical and regulatory outcomes following the first QT-related casualty.Ther Adv Drug Saf. 2018 Jun 18;9(8):475-493. doi: 10.1177/2042098618780854. eCollection 2018 Aug. Ther Adv Drug Saf. 2018. PMID: 30364900 Free PMC article. Review.